Want to join the conversation?
Medical device maker $BSX received FDA approval for SYNERGY Bioabsorbable Polymer Drug-Eluting Stent (BP-DES) for the treatment of CAD. $BSX to commence commercialization of the first & only BP-DES in the US immediately. Four-year EVOLVE trial of BP-DES data showed a continued 0% stent thrombosis rate & a low 1.1% rate of lesion revascularization.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.